Lip Cancer Market: By Diagnosis Test scan, MRI scan, positron emission tomography scan, chest X-ray, complete blood count , By Causes, Others, & By Region - Forecast 2016-2021

  • ID: 3974215
  • Report
  • Region: Global
  • 144 pages
  • IndustryARC
1 of 3
Lip cancers are development of abnormal cells that grow out of control and form lesions or tumors on the lips. They are the most common type of oral cancers. These cancers develop in thin, flat cells — called squamous cells — that line the lips, mouth, tongue, cheeks, sinuses, throat, and hard and soft palates. Symptoms of lip cancer include soreness, lumps or pale colored ulcers in the mouth that are usually painless at first but may become painful with disease progression. According to the National Institute of Dental and Craniofacial Research, most cases of oral cancer are linked to tobacco use and heavy alcohol use apart from that sun exposure is also a major risk factor, especially for people who work outdoors since they are more likely to have prolonged sun exposure. Globally increasing awareness is expected to drive the demand for lip cancer treatment during the period of study.

Geographically North America dominated global lip cancer market, due to higher awareness amongst its citizens advanced health care infrastructure, and technological advancement. North America was followed by Europe and Asia-Pacific as second and third largest market respectively. Asia Pacific is projected to have fastest growth, owing to rapidly increasing awareness, developing healthcare infrastructure and increasing spending on healthcare in developing nations such as China, and India in this region.

This report identifies the global lip cancer market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global lip cancer market.

This report segments global lip cancer market on the basis of diagnosis test, causes and regional market as follows:

Lip Cancer Market, By Diagnosis tests: computed tomography (CT) scan, MRI scan, positron emission tomography (PET) scan, chest X-ray, complete blood count (CBC))
The report has focused study on lip cancer market by basis of major causes such as: Smoking, Alcohol, human papillomavirus (HPV), Others
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the lip cancer market. Some of the major companies’ profiles in detail are as follows:

Astra Zeneca plc
Bristol Myers Squibb
Eli Lilly & Co.

Hofmann La Roche
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Lip Cancer Market – Market Overview

2. Executive Summary

3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Lip Cancer Market– Market Forces
4.1. Drivers
4.1.1. Increasing reported incidence of lip cancer globally
4.1.2. Increasing awareness about lip cancer in developing economies
4.2. Restraints
4.2.1. Higher cost of research and development
4.3. Opportunities
4.3.1. Emerging economies
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Lip Cancer Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Lip Cancer Market, By Diagnosis Test
6.1. computed tomography (CT) scan
6.2. MRI scan
6.3. positron emission tomography (PET) scan
6.4. chest X-ray
6.5. complete blood count (CBC)
6.6. Others

7. Lip Cancer Market, By Causes
7.1. Smoking
7.2. Alcohol
7.3. human papillomavirus (HPV)
7.4. Others

8. Lip Cancer Market, By Geography
8.1. Europe
8.1.1. Germany
8.1.2. France
8.1.3. Italy
8.1.4. Spain
8.1.5. Russia
8.1.6. U.K.
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.3.3. Mexico
8.4. Rest of the World (RoW)
8.4.1. Brazil
8.4.2. Rest of RoW

9. Lip Cancer – Market Entropy
9.1. Expansion
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
10.1. Astra Zeneca plc
10.2. Bristol Myers Squibb
10.3. Celgene
10.4. Eli Lilly & Co.
10.5. Hofmann La Roche
10.6. Pfizer
10.7. Sanofi Aventis
10.8. Teva Pharmaceuticals
10.9. Novartis AG
10.10. Cipla.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Bibliography
11.5. Compilation of Expert Insights
11.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown